Log in to save to my catalogue

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide st...

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide st...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1947651891

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

About this item

Full title

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-09, Vol.12 (9), p.e0183844-e0183844

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

To assess efficacy and safety of rituximab (RTX) as induction therapy, maintenance of remission and treatment of relapses in a cohort of IgG4-related disease (IgG4-RD) patients.
Nationwide retrospective multicenter study of IgG4-RD patients treated with at least one course of RTX. Clinical, biological and radiological response, relapse rate and...

Alternative Titles

Full title

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1947651891

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1947651891

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0183844

How to access this item